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Effects of Fructose-Derived Advanced Glycation End Products on
Acetylation of Histones in the Brain
Abstract
Objective: The objective of this study was to determine the effects of fructose and their advanced glycation
end products (fru-AGES) on histone acetylation in microglia, the immune cells of the brain.
Significance: Fru-AGES primarily form as a result of non-enzymatic reactions between fructose and proteins.
One result is inflammation in the brain, which can be directly correlated to increased microglia activity.
Microglial activity has been shown to be associated with the acetylation of histones, resulting in a change in
transcription of inflammatory genes. Elucidation of a direct link between fructose, fru-AGES and histone
acetylation would increase understanding the pathophysiology of inflammatory disorders such as Alzheimer’s
disease.
Experimental Procedures: An immortalized rat microglial cell line was treated in vitro with control media, fru-
AGES or fructose. Histone acetylation was analyzed indirectly through activity of histone deacetlyase
(HDAC) using the HDAC Glo I/II Assay (Promega). Chemiluminescent product formation was measuring
with a spectrophotometer.
Results Obtained: Both treatments with fructose and fru-AGES showed an increase in HDAC activity
compared to control by up to 35% and 20%, respectively, correlating to a decrease in global histone
acetylation. This is contradictory to initial expectations, as a decrease in acetylation could result in a decrease
in transcription of genes . Despite causing an initial inflammatory response, fructose and fru-AGES appear to
suppress overall gene transcription.
Conclusion: Previous data show that exposure of microglia to fructose and fru-AGES results in a pro-
inflammatory activated state. However, at the level of gene transcription, microglia may be desensitized and
less able to respond in the long term.
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Introduction
Microglia are considered the immune cells of the central
nervous system (CNS). They are found throughout the
brain and are seen in a ramified, or branched form when in
their resting state, allowing them to monitor the tissue that
surrounds them. Microglia will change into an amoeboid
form when they come in contact with a stimulus that is
detrimental to the CNS. These triggers can include
damaged neuronal cells, foreign matter, plaques,
pathogens, or other inflammatory triggers (e.g., advanced
glycation end products (AGEs)).1 Fructose, or fruit sugar, is
a naturally occurring simple sugar that is often found as a
sweetener in many industrial food products such as soft
drinks.2 Fructose is highly prevalent in the average
everyday American diet. With high consumption of
fructose, its reaction with proteins can cause the formation
of fructose advanced glycation end-products(Fru-AGES).
One result of the build up of these fru-AGES is
inflammation in the brain, which can be directly correlated
to increased microglia activity.3 Microglial activity has been
shown to be associated with the acetylation of histones, a
chemical modification that increases the accessibility of
DNA to transcriptional machinery.4 Increases in histone
acetylation is associated with increase gene transcription,
and vice versa. Elucidation of a direct link between
fructose, fru-AGES and histone acetylation would increase
understanding the pathophysiology of inflammatory
disorders such as Alzheimer’s disease.
Objective
Using prior knowledge of glucose, fructose and fru-AGES,
the objective of this study was to determine the effects of
fructose and their advanced glycation end products (fru-
AGES) on histone acetylation in microglia, the immune
cells of the brain. In order to determine this, we studied
changes in inflammatory gene expression after microglia
were exposed to fru-AGES. In addition, we analyzed
histone acetylation in microglia via changes in histone
deacetylase enzyme activity after being exposed to
fructose and fru-AGES.
Methods
Fru-AGEs were produced by incubating fructose with
bovine serum albumin for 8 weeks at 37°C.3 An
immortalized rat microglial cell line was treated in vitro with
control media, fru-AGES or fructose. A quantitative real-
time polymerase chain reaction (qRT-PCR) was performed
after the treatment of fru-AGES at a 24 hour time point at
concentrations of 0.8, 0.4, 0.2, and 0.1 µg/µL. The qRT-
PCR measured the gene expression of pro-inflammatory
markers such as complement 5 (C5) and tumor necrosis
factor α (TNFα) as well as cell-surface receptors such as
the toll-like receptor 4 (TLR4). Histone acetylation was
analyzed indirectly through activity of histone deacetlyase
(HDAC) using the HDAC Glo I/II Assay (Promega
Corporation), after 3 hours of treatment with fruAGEs or
fructose concentrations of 100, 50 , 25 or 10 mM.
Chemiluminescent product formation was measured with a
spectrophotometer and directly correlated with HDAC
activity.
Conclusions
 Gene expression analyses of TNF alpha and C5
showed up to a 6-fold increase in gene
expression with the treatment of fru-AGES 24
hours prior to analysis. The TLR4 gene
expression decreased after the treatment with
higher doses of fru-AGEs. This confirms that fru-
AGEs elicit an inflammatory response in
microglia, producing an activated phenotype.
 Both treatments with fructose and fru-AGES
showed an increase in HDAC activity compared
to control by up to 80% and 40%, respectively,
correlating to a decrease in global histone
acetylation. This is contradictory to initial
expectations, as a decrease in acetylation could
result in a decrease in transcription of genes.
Despite increase in inflammatory cytokine gene
transcription (TNFalpha and C5), fructose and
fru-AGES appear to suppress overall gene
transcription. This is reflected in TLR4
expression.
 Previous data show that exposure of microglia
to fructose and fru-AGES results in a pro-
inflammatory activated state. However, at the
level of gene transcription, microglia may be
desensitized and less able to respond in the
long term.
 It is possible that gene transcription may be
altered earlier than 24 hours, and a 3 hour
treatment plan for the gene expression assay
may be beneficial to obtain in future
experiments.
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Figure 5: During qRT-PCR, the primers anneal 
to the DNA, cleaving the probe containing the 
gene expression markers, causing the probe 
and quencher to be released from the reporter 
and the DNA fragment, resulting in a signal 
from the reporter5.
Figure 1: When in 
contact with 
inflammatory signals, 
activated microglia 
release pro-
inflammatory 
molecules like 
cytokines and 
reactive oxygen 
species. These
can be deleterious to 
neurons in high 
concentrations 
suggesting the role in 
neurodegeneration. 
This figure is adapted 
from Lull, 2007.1
Figure 4: A) Cells were treated with Fru-AGES and then the chemiluminesence 
from the HDAC activity was measured 3 hours after treatment, showing  up to a 
20% increase. B) Cells were treated with fructose and the HDAC activity was 
measured, showing up to a 37% increase.  Increased HDAC activity would 
correlate to an global decrease in histone acetylation after treatment with fructose 
or fru-AGEs. 
Figure 2: Schematic of the production of Advanced Glycation 
Endproducts (AGEs). This mechanism can be utilized in the 
body with glucose and fructose when they come in contact with 
a  protein which produces the AGEs used in our experimental 
procedure.  These AGEs can then go  on to produce 
inflammation and tissue damage in the body.
Figure 3: Histone deacetylase (HDAC) activity was 
measured using the HDAC Glo I/II Assay Kit from 
Promega Corporation.  The assay utilizes the 
reaction shown above to produce 
chemiluminesence proportional to the level of HDAC 
activity. The luminescence glow that can then be 
measured using a spectrophotometer.6
Figure 6: Expression of genes related to 
microglial activation and inflammation was 
measured. Three genes, tumor necrosis 
factor alpha (TNFalpha), complement 5 
(C5), and toll-like receptor 4 (TLR4) were 
analyzed for expression after the addition 
of  increasing concentrations of fru-AGES 
to microglia 24 hours prior. Results 
determined an increase in both TNF alpha 
and C5 (0.8 µg/µL and 0.2 µg/µL 
treatments resulted in inconclusive data for  
C5 expression). TLR4 gene expression 
decreased slightly at the three highest 
doses of fru-AGE.
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